Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions
Aptar has entered into an enterprise agreement with Biogen Inc. (Nasdaq: BIIB) to o…
U.S. Healthcare Industry Races Toward Digital Future
Healthcare providers and insurers look to digital records and tools to boost quality and efficiency, with GenAI emerging as next major trend, ISG Provider Lens™ report saysSTAMFORD, Conn.--(BUSINESS WIRE)--$III #DigitalHealthcare--Healthcare companies...
Empatica’s Medical-Grade EmbracePlus Wearable Selected for Critical US Department of Defense PTSD Treatment Study
Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health monitoring and diagnostics, today announced that they have been chosen by the United States Department of Defense (DoD) Defense Health Agency’s Posttraumatic Stress Disorder Drug Treatment Program as a technology partner for a clinical study aimed at developing new therapies to treat PTSD.
Introducing the new Visage Ease VP for Apple Vision Pro
Visage has unveiled Visage Ease VP, software tailored for Apple's newly launched sp…
URMC Announces First-of-its-Kind Alliance to Expand Health Care Access to Rural Communities
The University of Rochester Medical Center today announced a first-of-its-kind initiative to improve health care access and wellness outcomes in rural communities in Upstate New York through the distribution of telehealth stations conveniently located at local bank branches.
Cedars-Sinai unveils a revolutionary mental health support app powered by Apple Vision Pro
Cedars-Sinai, a renowned healthcare institution, introduces a groundbreaking applic…
Everly Health and National Kidney Foundation Partnership Aims to Save Lives Through Early Detection of Chronic Kidney Disease
Program drives increased education and access to high-quality testing for early detection to protect kidney health and lower healthcare costsAUSTIN, Texas--(BUSINESS WIRE)--Everly Health, a leading remote-based healthcare company expanding access to v...
Vektor Medical Secures $16 Million Series A Funding
Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science. This funding underscores investor confidence in Vektor’s vision and ability to successfully execute its mission to revolutionize arrhythmia care.
Clinical Utility of FEops AI-enabled Predictive Pre-planning for LAAO Demonstrated in US
Data from the first US comprehensive single center experience at St Bernard’s Medical Center and Arrhythmia Research Group, presented at a Late-Breaking session at the AF Symposium 2024 in Boston, shows that Left Atrial Appendage Occlusion (LAAO) procedures planned by means of FEops HEARTguideTM result in significantly improved procedural efficiency.
Australia unveils a 10-Year Digital Health Blueprint
Australia has laid out an ambitious "10-year Digital Health Blueprint" aimed at rei…